Grant Skrepnek to Humans
This is a "connection" page, showing publications Grant Skrepnek has written about Humans.
Connection Strength
1.127
-
Experience using a state board of pharmacy adequate staffing form: A descriptive report. Curr Pharm Teach Learn. 2025 Jun; 17(6):102326.
Score: 0.055
-
Adherence, Persistence, Readmissions, and Costs in Medicaid Members with Schizophrenia or Schizoaffective Disorder Initiating Paliperidone Palmitate Versus Switching Oral Antipsychotics: A Real-World Retrospective Investigation. Adv Ther. 2023 Jan; 40(1):349-366.
Score: 0.047
-
Readmissions, costs, and duration to subsequent outpatient visit after hospital discharge among Medicaid beneficiaries utilizing oral versus long-acting injectable antipsychotics in bipolar disorder or schizophrenia. Curr Med Res Opin. 2022 Sep; 38(9):1621-1630.
Score: 0.046
-
A National Assessment of Alzheimer Disease and Antipsychotic Medication Prescribing Among Older Adults in Ambulatory Care Settings. Alzheimer Dis Assoc Disord. 2022 Jul-Sep 01; 36(3):230-237.
Score: 0.046
-
Clinical and economic outcomes associated with hospitalizations for acute idiopathic pericarditis in the United States. Heart Lung. 2021 Nov-Dec; 50(6):825-831.
Score: 0.043
-
Management of Acute Idiopathic (Viral) Pericarditis in the Emergency Department: A Review for the Nursing Professional. Adv Emerg Nurs J. 2020 Jan/Mar; 42(1):17-29.
Score: 0.039
-
Hepatitis C Direct-Acting Antiviral Treatment Selection, Treatment Failure, and Use of Drug-Drug Interactions in a State Medicaid Program. J Manag Care Spec Pharm. 2019 Nov; 25(11):1261-1267.
Score: 0.038
-
National estimates of case-mix, mortality, and economic outcomes among inpatient HIV/AIDS mono-infection and hepatitis C co-infection cases in the US. J Eval Clin Pract. 2019 Oct; 25(5):806-821.
Score: 0.036
-
Career Skills Assessment in a Doctor of Pharmacy Curriculum. Am J Pharm Educ. 2018 09; 82(7):6300.
Score: 0.035
-
Assessment of the effect of an enhanced prior authorization and management program in a United States Medicaid program on chronic hepatitis C treatment adherence and cost. J Am Pharm Assoc (2003). 2018 Sep - Oct; 58(5):485-491.
Score: 0.035
-
Sustained Virologic Response and Costs Associated with Direct-Acting Antivirals for Chronic Hepatitis C Infection in Oklahoma Medicaid. J Manag Care Spec Pharm. 2018 Jul; 24(7):664-676.
Score: 0.035
-
Death or Debt? National Estimates of Financial Toxicity in Persons with Newly-Diagnosed Cancer. Am J Med. 2018 10; 131(10):1187-1199.e5.
Score: 0.035
-
Health Care Service and Outcomes Among an Estimated 6.7 Million Ambulatory Care Diabetic Foot Cases in the U.S. Diabetes Care. 2017 07; 40(7):936-942.
Score: 0.032
-
Clinical and economic characteristics of emergency department visits due to acetaminophen toxicity in the USA. BMJ Open. 2015 Sep 09; 5(9):e007368.
Score: 0.029
-
A Diabetic Emergency One Million Feet Long: Disparities and Burdens of Illness among Diabetic Foot Ulcer Cases within Emergency Departments in the United States, 2006-2010. PLoS One. 2015; 10(8):e0134914.
Score: 0.028
-
Foot-in-wallet disease: tripped up by "cost-saving" reductions? Diabetes Care. 2014 Sep; 37(9):e196-7.
Score: 0.027
-
Emergency department visits in the United States for pediatric depression: estimates of charges and hospitalization. Acad Emerg Med. 2014 Sep; 21(9):1003-14.
Score: 0.027
-
Open bypass and endovascular procedures among diabetic foot ulcer cases in the United States from 2001 to 2010. J Vasc Surg. 2014 Nov; 60(5):1255-1265.
Score: 0.026
-
Quality-adjusted time without symptoms or toxicity (Q-TWiST): patient-reported outcome or mathematical model? A systematic review in cancer. Psychooncology. 2015 Mar; 24(3):253-61.
Score: 0.026
-
Determinants of life expectancy in the Eastern Mediterranean Region. Health Policy Plan. 2015 Jun; 30(5):624-37.
Score: 0.026
-
Clinical and economic burden of Richter syndrome in inpatient cases of chronic lymphocytic leukemia within the United States, 2001-2010. Leuk Lymphoma. 2014 Apr; 55(4):834-40.
Score: 0.025
-
Health care expenditures, hospitalizations, and productivity associated with cancer in US employer settings. J Occup Environ Med. 2012 Dec; 54(12):1453-60.
Score: 0.024
-
Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality. COPD. 2012 Apr; 9(2):131-41.
Score: 0.022
-
Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S. Gen Dent. 2010 Nov-Dec; 58(6):484-92; quiz 493-4.
Score: 0.020
-
Development of computerized alerts with management strategies for 25 serious drug-drug interactions. Am J Health Syst Pharm. 2009 Jan 01; 66(1):38-44.
Score: 0.018
-
The cost-effectiveness of sertraline in the treatment of depression. Expert Opin Pharmacother. 2008 Oct; 9(14):2497-508.
Score: 0.018
-
Relationship between pharmaceutical services characteristics and exposure rates to drug-drug interactions in Veterans Affairs medical centers. Am J Health Syst Pharm. 2008 Sep 15; 65(18):1744-9.
Score: 0.018
-
Incremental effects of concurrent pharmacotherapeutic regimens for heart failure on hospitalizations and costs. Ann Pharmacother. 2005 Nov; 39(11):1785-91.
Score: 0.014
-
Cost-efficacy of imatinib versus allogeneic bone marrow transplantation with a matched unrelated donor in the treatment of chronic myelogenous leukemia: a decision-analytic approach. Pharmacotherapy. 2005 Mar; 25(3):325-34.
Score: 0.014
-
An economic and outcomes assessment of first-line monotherapy in the treatment of community-acquired pneumonia within managed care. Curr Med Res Opin. 2005 Feb; 21(2):261-70.
Score: 0.014
-
Epidemiology, clinical and economic burden, and natural history of chronic obstructive pulmonary disease and asthma. Am J Manag Care. 2004 Jul; 10(5 Suppl):S129-38.
Score: 0.013
-
An assessment of therapeutic regimens in the treatment of acute exacerbations in chronic obstructive pulmonary disease and asthma. Am J Manag Care. 2004 Jul; 10(5 Suppl):S139-52.
Score: 0.013
-
Prediction and Comparison of Fentanyl Infusion Pharmacokinetics in Obese and Nonobese Children. Pediatr Crit Care Med. 2019 12; 20(12):e556-e564.
Score: 0.010
-
Optimal Medical Therapy Prescribing Patterns and Disparities Identified in Patients with Acute Coronary Syndromes at an Academic Medical Center in an Area with High Coronary Heart Disease-Related Mortality. Am J Cardiovasc Drugs. 2019 Apr; 19(2):185-193.
Score: 0.009
-
Low-dose versus high-dose methadone for the management of neonatal abstinence syndrome. J Opioid Manag. 2019 Mar/Apr; 15(2):159-167.
Score: 0.009
-
Fidaxomicin versus oral vancomycin for severe Clostridium difficile infection: a retrospective cohort study. Clin Microbiol Infect. 2019 Aug; 25(8):987-993.
Score: 0.009
-
Clinical outcomes of fidaxomicin vs oral vancomycin in recurrent Clostridium difficile infection. J Clin Pharm Ther. 2019 Apr; 44(2):220-228.
Score: 0.009
-
Sleep-Disordered Breathing is Associated With Increased Mortality in Hospitalized Infants With Congenital Heart Disease. J Clin Sleep Med. 2018 09 15; 14(9):1551-1558.
Score: 0.009
-
Overview of Prescription Opioid Deaths in the Oklahoma State Medicaid Population, 2012-2016. Med Care. 2018 08; 56(8):727-735.
Score: 0.009
-
Detectable Concentrations of Inhaled Tobramycin in Critically Ill Children Without Cystic Fibrosis: Should Routine Monitoring Be Recommended? Pediatr Crit Care Med. 2017 Dec; 18(12):e615-e620.
Score: 0.008
-
Clostridium difficile treatment in neutropenic patients: Clinical outcomes of metronidazole, vancomycin, combinations, and switch therapy. J Oncol Pharm Pract. 2019 Apr; 25(3):520-528.
Score: 0.008
-
Relationship between rate of fentanyl infusion and time to achieve sedation in nonobese and obese critically ill children. Am J Health Syst Pharm. 2017 Aug 01; 74(15):1174-1183.
Score: 0.008
-
HIV Pharmacist's Impact on Inpatient Antiretroviral Errors. HIV Med. 2016 11; 17(10):717-723.
Score: 0.008
-
State Medicaid Programs Bring Managed Care Tenets to Fee for Service. J Manag Care Spec Pharm. 2016 Feb; 22(2):145-8.
Score: 0.007
-
Administration of first dose antibiotic in the ED in patients with minor skin and soft tissue infections. Am J Emerg Med. 2015 Sep; 33(9):1225-8.
Score: 0.007
-
Intramuscular interferon beta-1a and evolving treatment options and outcomes measurement for MS: considerations for managed care. J Manag Care Pharm. 2013 Jan-Feb; 19(1 Suppl A):S1-53.
Score: 0.006
-
Perspectives for managed care organizations on the burden of multiple sclerosis and the cost-benefits of disease-modifying therapies. J Manag Care Pharm. 2013 Jan-Feb; 19(1 Suppl A):S41-53.
Score: 0.006
-
Effect of epidural analgesia on postoperative complications following pancreaticoduodenectomy. Am J Surg. 2012 Dec; 204(6):1000-4; discussion 1004-6.
Score: 0.006
-
Long-term persistency and costs associated with the use of iron chelation therapies in the treatment of Sickle cell disease within Medicaid programs. J Med Econ. 2013; 16(1):10-8.
Score: 0.006
-
Induction dose of propofol for pediatric patients undergoing procedural sedation in the emergency department. Pediatr Emerg Care. 2012 May; 28(5):440-2.
Score: 0.006
-
Oncologist preferences for health states associated with the treatment of advanced ovarian cancer. Appl Health Econ Health Policy. 2010; 8(4):217-23.
Score: 0.005
-
Potential determinants of prescribers' drug-drug interaction knowledge. Res Social Adm Pharm. 2008 Dec; 4(4):355-66.
Score: 0.004
-
Cost-effectiveness of urokinase and alteplase for treatment of acute peripheral artery disease: comparison in a decision analysis model. Am J Health Syst Pharm. 2008 Aug 01; 65(15):1435-42.
Score: 0.004
-
Use of salmeterol with and without concurrent use of inhaled corticosteroids and the risk of asthma-related hospitalization among patients with asthma. Curr Med Res Opin. 2008 Mar; 24(3):859-67.
Score: 0.004
-
Prescribers' knowledge of and sources of information for potential drug-drug interactions: a postal survey of US prescribers. Drug Saf. 2008; 31(6):525-36.
Score: 0.004
-
Reasons provided by prescribers when overriding drug-drug interaction alerts. Am J Manag Care. 2007 Oct; 13(10):573-8.
Score: 0.004
-
Potential drug-drug interactions within Veterans Affairs medical centers. Am J Health Syst Pharm. 2007 Jul 15; 64(14):1500-5.
Score: 0.004
-
Peginterferon alfa-2a versus peginterferon alfa-2b as initial treatment of hepatitis C virus infection: a cost-utility analysis from the perspective of the Veterans Affairs Health Care System. Pharmacotherapy. 2007 Jun; 27(6):813-24.
Score: 0.004
-
Pharmacist workload and pharmacy characteristics associated with the dispensing of potentially clinically important drug-drug interactions. Med Care. 2007 May; 45(5):456-62.
Score: 0.004
-
A meta-analysis of the efficacy of intraperitoneal cisplatin for the front-line treatment of ovarian cancer. Int J Gynecol Cancer. 2007 May-Jun; 17(3):561-70.
Score: 0.004
-
Curriculum mapping in program assessment and evaluation. Am J Pharm Educ. 2007 Apr 15; 71(2):20.
Score: 0.004
-
Use of reflective portfolios in health sciences education. Am J Pharm Educ. 2007 Apr 15; 71(2):34.
Score: 0.004
-
Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial. Curr Med Res Opin. 2007 Feb; 23(2):245-50.
Score: 0.004
-
Cost-utility comparison of escitalopram and sertraline in the treatment of major depressive disorder. Curr Med Res Opin. 2007 Feb; 23(2):251-8.
Score: 0.004
-
Persistence, adherence, and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapies. J Am Board Fam Med. 2007 Jan-Feb; 20(1):72-80.
Score: 0.004
-
Community pharmacy managers' perception of computerized drug-drug interaction alerts. J Am Pharm Assoc (2003). 2006 Mar-Apr; 46(2):148-53.
Score: 0.004